Abstract
A generalized biological effective dose (gBED) model was developed. The model accounts for non-uniform dose distribution and varying dose fractionation schemes commonly encountered in spine stereotactic body radiotherapy. The gBED calculation was applied to a multi-institutional clinical data to model myelopathy and spinal cord tolerance. Despite recent animal data suggesting partial volume tolerance, our study found that the dose at which myleopathy is observed correlated with the dose received in a small volume such as 0.1 cc. Our results justify the practice of constraining the dose to the small absolute volume for safe treatment to the spinal cord given modern intensity modulated radiotherapy. By accounting for dose inhomogeneity, the gBED was also found to be more sensitive than the traditional BED in predicting spinal cord tolerance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ma, L., Sahgal, A., Larson, D.A. (2009). Tolerance of the Spinal Cord to Hypofractionated Radiotherapy Based on a Generalized Biological Effective Dose (gBED) Model. In: Dössel, O., Schlegel, W.C. (eds) World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany. IFMBE Proceedings, vol 25/1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03474-9_288
Download citation
DOI: https://doi.org/10.1007/978-3-642-03474-9_288
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03472-5
Online ISBN: 978-3-642-03474-9
eBook Packages: EngineeringEngineering (R0)